Literature DB >> 3108961

Kinetic studies on the inactivation of 5-lipoxygenase by 5(S)-hydroperoxyeicosatetraenoic acid.

D Aharony, D G Redkar-Brown, S J Hubbs, R L Stein.   

Abstract

The oxygenation of arachidonic acid (AA) by guinea-pig neutrophil 5-lipoxygenase terminates prematurely at a substrate utilization of only 50%. In the presence of dithiothreitol (DTT), reaction progress continues longer but still terminates prematurely, at about 70% substrate turnover. The addition of more substrate during the first 60 seconds of the initial reaction resulted in continued product formation. However, at times after 120 seconds, the addition of more AA could not produce additional product formation. Together, these results indicate a time-dependent (t1/2 = 0.5-1.0 min), irreversible loss of enzyme activity. To determine if the product 5-hydroperoxy-6,8,11,14-eicosatetraenoic acid (5-HPETE) mediates the inactivation, it was tested for its ability to irreversibly inhibit the enzyme and found to inactivate 5-lipoxygenase with Ki = 0.05 +/- 0.01 microM and ki = 1.4 +/- 0.4 min-1. DTT changed the apparent affinity of 5-HPETE (Ki = 0.33 +/- 0.09 microM) but had no effect on the rate of inactivation (ki = 1.26 +/- 0.62 min-1). In contrast, the hydroxy derivative of 5-HPETE, 5-hydroxy-6,8,11,14-eicosatetraenoic acid (5-HETE), is a reversible, time-independent inhibitor with Ki = 6.3 +/- 0.9 microM regardless of DTT. The ability of thiols to protect 5-lipoxygenase from production inactivation is due, at least in part, to a non-enzymatic reaction between DTT and 5-HPETE that converts the hydroperoxy acid to a material that can no longer inactivate the enzyme.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3108961     DOI: 10.1016/0090-6980(87)90307-8

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  9 in total

1.  Heneicosapentaenoate (21:5n-3): its incorporation into lipids and its effects on arachidonic acid and eicosanoid synthesis.

Authors:  L N Larsen; K Høvik; J Bremer; K H Holm; F Myhren; B Børretzen
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

2.  Identification of the Substrate Access Portal of 5-Lipoxygenase.

Authors:  Sunayana Mitra; Sue G Bartlett; Marcia E Newcomer
Journal:  Biochemistry       Date:  2015-10-08       Impact factor: 3.162

3.  Capacity for repeatable leukotriene generation after transient stimulation of mast cells and macrophages.

Authors:  T G Brock; R W McNish; M Peters-Golden
Journal:  Biochem J       Date:  1998-02-01       Impact factor: 3.857

4.  Evaluation of 5- and 6-fluoro derivatives of arachidonic acid and 5,8,14-eicosatrienoic acid as substrates and inhibitors of 5-lipoxygenase.

Authors:  J F Navé; D Jacobi; C Gaget; B Dulery; J B Ducep
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

5.  A 5‑lipoxygenase-specific sequence motif impedes enzyme activity and confers dependence on a partner protein.

Authors:  Erin E Schexnaydre; Jana Gerstmeier; Ulrike Garscha; Paul M Jordan; Oliver Werz; Marcia E Newcomer
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-10-03       Impact factor: 4.698

6.  Regulation of leukotriene and 5oxoETE synthesis and the effect of 5-lipoxygenase inhibitors: a mathematical modeling approach.

Authors:  Tatiana A Karelina; Kirill V Zhudenkov; Oleg O Demin; Dmitry V Svetlichny; Balaji Agoram; David Fairman; Oleg V Demin
Journal:  BMC Syst Biol       Date:  2012-11-12

7.  Systems pharmacology models can be used to understand complex pharmacokinetic-pharmacodynamic behavior: an example using 5-lipoxygenase inhibitors.

Authors:  O Demin; T Karelina; D Svetlichniy; E Metelkin; G Speshilov; O Demin; D Fairman; P H van der Graaf; B M Agoram
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-09-11

8.  Comparative analysis and modeling of the severity of steatohepatitis in DDC-treated mouse strains.

Authors:  Vikash Pandey; Marc Sultan; Karl Kashofer; Meryem Ralser; Vyacheslav Amstislavskiy; Julia Starmann; Ingrid Osprian; Christina Grimm; Hendrik Hache; Marie-Laure Yaspo; Holger Sültmann; Michael Trauner; Helmut Denk; Kurt Zatloukal; Hans Lehrach; Christoph Wierling
Journal:  PLoS One       Date:  2014-10-27       Impact factor: 3.240

Review 9.  Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?

Authors:  Nils Helge Schebb; Hartmut Kühn; Astrid S Kahnt; Katharina M Rund; Valerie B O'Donnell; Nicolas Flamand; Marc Peters-Golden; Per-Johan Jakobsson; Karsten H Weylandt; Nadine Rohwer; Robert C Murphy; Gerd Geisslinger; Garret A FitzGerald; Julien Hanson; Claes Dahlgren; Mohamad Wessam Alnouri; Stefan Offermanns; Dieter Steinhilber
Journal:  Front Pharmacol       Date:  2022-03-02       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.